07/09/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 7/9/2020. This 10-page document is an update to the scientific brief published on March 29, 2020, entitled “Modes of transmission of virus causing COVID-19: Implications for infection prevention and control (IPC) precaution recommendations,” and includes new scientific evidence available on transmission of SARS-CoV-2, the virus that causes COVID-19. Airborne transmission of the virus can occur in healthcare settings where specific medical procedures, called aerosol generating procedures, generate very small droplets called aerosols. Some outbreak reports related to indoor crowded spaces have suggested the possibility of aerosol transmission, combined with droplet transmission, for example, during choir practice, in restaurants, or in fitness classes. (PDF)
07/08/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 7/8/2020. This web page outlines strategies for implementation of infection prevention and control (IPC) guidance for non-U.S. outpatient care settings in response to community spread of coronavirus disease-2019 (COVID-19). Clinics and facilities that provide outpatient services play an important role in a healthcare system’s response to COVID-19 and are critical to provide continued essential health services. (Text)
07/06/2020 12:00 AM EDT
Source: Washington State Department of Health. Published: 7/6/2020. This 18-page report, published with the University of Washington MetaCenter for Pandemic Preparedness and Global Health Security and the UW START (Strategic Analysis, Research and Training) Center, is a brief summary of the models and implementation approaches to re-opening schools that focuses on the approaches used in 15 countries for which data were available. (PDF)
07/03/2020 12:00 AM EDT
Source: World Health Organization, Regional Office for Africa. Published: 7/3/2020. This seven-page rapid policy brief aims to summarize relevant research about the use of corticosteroids in patients with COVID-19 pneumonia, facilitating the findings' use in decision-making. It summarizes search and research methods, and policy findings. (PDF)
07/02/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/2/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the BD Veritor™ System for Rapid Detection of SARS-CoV-2. The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is authorized for use using nasal swab specimens collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms. (PDF)
07/02/2020 12:00 AM EDT
Source: Occupational Safety and Health Administration [U.S. Department of Labor] (OSHA). Published: 7/2/2020. This web page provides frequently asked questions (FAQs) and answers related to the coronavirus disease 2019 (COVID-19) pandemic. Questions are grouped by topic, and cover General Information; Cleaning and Disinfection; Construction; Cloth Face Coverings; Employer Requirements; Healthcare; Personal Protective Equipment; Restrooms and Handwashing Facilities; Retaliation; Return to Work; Testing for COVID-19; Training; and Worker Protection Concerns. (Text)
07/01/2020 12:00 AM EDT
Source: World Health Organization, Regional Office for the Western Pacific. Published: 7/2020. During epidemics and public health emergencies, decision-makers make timely decisions to save lives, and they make these decisions while faced with many uncertainties and limited information. This 68-page document describes epidemic analysis for response decision-making (ERD), which is a practical process for informing response decisions by systematically and logically organizing multi-source information to optimize assessment of epidemic situation. ERD aims to justify and inform decisions based on how surveillance data are synthesized and interpreted, and helps to reduce the chances of misinterpreting the situation. (PDF)
07/01/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 7/2020. During the Joint External Evaluation (JEE) mission on October 28-November 1, 2019, Brunei Darussalam’s capacities in 19 technical areas were evaluated through a peer-to-peer process that brought subject matter experts together with members of the JEE team for a week of collaborative discussion and field visits. This 98-page report summarizes the evaluation. (PDF)
07/01/2020 12:00 AM EDT
Source: RAND Corporation. Published: 7/2020. This 42-page report examines assessment criteria for early-stage and late-stage models, taking into account the effects of the COVID-19 pandemic on behavior, policy, health outcomes, and the economy. The authors of this report reviewed available models and the relevant literature to produce a framework for assessing a model's suitability for policymakers in the Commonwealth of Virginia. (PDF)
06/30/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/30/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the SCoV-2 Detect™ IgM ELISA. The SCoV-2 Detect™ IgM ELISA is authorized for the detection of IgM antibodies to SARS-CoV-2 in human serum. (PDF)
06/26/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/26/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of Access SARS-CoV-2 IgG. Access SARS-CoV-2 IgG is authorized for the detection of IgG antibodies to SARS-CoV-2 in human serum, serum separator tubes, and plasma (lithium heparin, dipotassium EDTA, tripotassium EDTA, sodium citrate). (PDF)
06/26/2020 12:00 AM EDT
Source: U.S. House of Representatives, Committee on Oversight and Reform. Published: 6/26/2020. This one-hour, 57-minute hybrid in-person/remote hearing of the House Select Committee on the Coronavirus Crisis discusses a new report from the Government Accountability Office (GAO) with recommendations to improve the federal coronavirus response. (Video or Multimedia)
06/19/2020 12:00 AM EDT
Source: World Health Organization, Regional Office for the Western Pacific. Published: 6/19/2020. The set of guiding principles and stepwise approach outlined in this 16-page document aim to support Member States throughout their decision-making process of identifying, assessing, adopting, and adapting emergent digital contact tracing and quarantine (DCTQ) tools for COVID-19, which offer the potential to complement and strengthen conventional contact tracing initiatives on an unprecedented scale. (PDF)
06/09/2020 12:00 AM EDT
Source: U.S. Government Accountability Office (GAO). Published: 6/9/2020. This 58-page report examines the characteristics of school shootings and affected schools, and what is known about the link between discipline and school shootings. It found that half were committed by current or former students. (PDF)
05/01/2020 12:00 AM EDT
Source: World Health Organization, Regional Office for Europe. Published: 5/2020. This web page provides technical guidance notes with checklists that provide in-depth pragmatic policy recommendations to strengthen the health system response to COVID-19, and include emergent country-specific practices. (Text)
No hay comentarios:
Publicar un comentario